Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06183580 · ClinicalTrials.gov registry record · Phase 1
Teen Brain Training (TBT)
A Phase 1 study, sponsored by University of Minnesota.
- Completed
- Registry status
- Phase 1
- Development phase
- 157
- Enrollment target
NCT06183580: Completed Phase 1 study, sponsored by University of Minnesota.
NCT06183580 is a Phase 1 study that has completed, run by University of Minnesota. The registered enrollment target is 157 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (162% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06183580, a Phase 1 study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 157 participants
- Enrollment target
Study Summary
A non invasive treatment study including participants at risk for suicide attempts and undergoing neurofeedback training. Neurofeedback is controlling your brain activity in real time inside the scanner.
Primary Outcome
The CSSRS has a scale 0-5 with 0 indicating no suicide ideation and 5 indicating suicide ideation with intent and plan. Higher values are considered the worst outcome The units are ordinal units scored by a clinician following the descriptions in the instrument. Suicidal Ideation Severity Subscale: This core scale has a range of 0 to 5. 0 = No suicidal ideation 1. = Wish to be dead 2. = Non-specific active suicidal thoughts 3. = Active suicidal ideation with method (not plan) 4. = Active suici
Interventions
- OTHER neurofeedback training involving dACC
- OTHER neurofeedback training involving amygdala
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 157 participants |
| Start Date | 2022-05-28 |
| Est. Completion | 2024-02-18 |
| Phase | Phase 1 |
What the finished NCT06183580 record still lists
NCT06183580 is an interventional study that assigns participants to a tested intervention. The registered 157 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (162% higher).
The record links to 0 conditions, and to 2 interventions - of which neurofeedback training involving dACC is the first listed.
NCT06183580 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06183580 about?
NCT06183580 is a clinical study titled "Teen Brain Training (TBT)". A non invasive treatment study including participants at risk for suicide attempts and undergoing neurofeedback training. Neurofeedback is controlling your brain activity in real time inside the scanner.
What is the current status of trial NCT06183580?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 157 participants. The study started on 2022-05-28. Estimated completion is 2024-02-18.
What interventions are being tested in trial NCT06183580?
The interventions under investigation include: neurofeedback training involving dACC (OTHER), neurofeedback training involving amygdala (OTHER).
Who is sponsoring clinical trial NCT06183580?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06183580's enrollment target sits among peer trials
157 351st of 2000 higher than 1,650 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05052541 · 157 participants · Phase 3
Safety and Efficacy of Oral Cannabis in Chronic Spine Pain
- NCT05076942 · 157 participants · Phase 2
Groningen International Study on Sentinel Nodes in Vulvar Cancer-III
- NCT06396598 · 157 participants · NA
Electronic Symptom Monitoring Program for Triggered Palliative Referrals in Patients With Thoracic Cancer
- NCT06655246 · 157 participants · Phase 1
A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI